United States Restriction Endonucleases Market Report & Forecast 2021-2027

United States Restriction Endonucleases Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Restriction Endonucleases Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Restriction Endonucleases Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Restriction Endonucleases Overall Market Size
2.1 United States Restriction Endonucleases Market Size: 2021 VS 2027
2.2 United States Restriction Endonucleases Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Restriction Endonucleases Sales: 2016-2027
3 Company Landscape
3.1 Top Restriction Endonucleases Players in United States Market
3.2 Top United States Restriction Endonucleases Companies Ranked by Revenue
3.3 United States Restriction Endonucleases Revenue by Companies
3.4 United States Restriction Endonucleases Sales by Companies
3.5 United States Restriction Endonucleases Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Restriction Endonucleases Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Restriction Endonucleases Product Type
3.8 Tier 1, Tier 2 and Tier 3 Restriction Endonucleases Players in United States Market
3.8.1 List of Tier 1 Restriction Endonucleases Companies in United States
3.8.2 List of Tier 2 and Tier 3 Restriction Endonucleases Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Restriction Endonucleases Market Size Markets, 2021 & 2027
4.1.2 Type I
4.1.3 Type II
4.1.4 Type III
4.1.5 Type IV
4.1.6 Others
4.2 By Type - United States Restriction Endonucleases Revenue & Forecasts
4.2.1 By Type - United States Restriction Endonucleases Revenue, 2016-2021
4.2.2 By Type - United States Restriction Endonucleases Revenue, 2022-2027
4.2.3 By Type - United States Restriction Endonucleases Revenue Market Share, 2016-2027
4.3 By Type - United States Restriction Endonucleases Sales & Forecasts
4.3.1 By Type - United States Restriction Endonucleases Sales, 2016-2021
4.3.2 By Type - United States Restriction Endonucleases Sales, 2022-2027
4.3.3 By Type - United States Restriction Endonucleases Sales Market Share, 2016-2027
4.4 By Type - United States Restriction Endonucleases Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Restriction Endonucleases Market Size, 2021 & 2027
5.1.2 Academic & Research Institutes
5.1.3 Hospitals & Diagnostic Centers
5.1.4 Biopharmaceutical
5.1.5 Others
5.2 By Application - United States Restriction Endonucleases Revenue & Forecasts
5.2.1 By Application - United States Restriction Endonucleases Revenue, 2016-2021
5.2.2 By Application - United States Restriction Endonucleases Revenue, 2022-2027
5.2.3 By Application - United States Restriction Endonucleases Revenue Market Share, 2016-2027
5.3 By Application - United States Restriction Endonucleases Sales & Forecasts
5.3.1 By Application - United States Restriction Endonucleases Sales, 2016-2021
5.3.2 By Application - United States Restriction Endonucleases Sales, 2022-2027
5.3.3 By Application - United States Restriction Endonucleases Sales Market Share, 2016-2027
5.4 By Application - United States Restriction Endonucleases Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 New England Biolabs
6.1.1 New England Biolabs Corporation Information
6.1.2 New England Biolabs Overview
6.1.3 New England Biolabs Restriction Endonucleases Sales and Revenue in United States Market (2016-2021)
6.1.4 New England Biolabs Restriction Endonucleases Product Description
6.1.5 New England Biolabs Recent Developments
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Corporation Information
6.2.2 Thermo Fisher Scientific Overview
6.2.3 Thermo Fisher Scientific Restriction Endonucleases Sales and Revenue in United States Market (2016-2021)
6.2.4 Thermo Fisher Scientific Restriction Endonucleases Product Description
6.2.5 Thermo Fisher Scientific Recent Developments
6.3 Takara Bio
6.3.1 Takara Bio Corporation Information
6.3.2 Takara Bio Overview
6.3.3 Takara Bio Restriction Endonucleases Sales and Revenue in United States Market (2016-2021)
6.3.4 Takara Bio Restriction Endonucleases Product Description
6.3.5 Takara Bio Recent Developments
6.4 Illumina
6.4.1 Illumina Corporation Information
6.4.2 Illumina Overview
6.4.3 Illumina Restriction Endonucleases Sales and Revenue in United States Market (2016-2021)
6.4.4 Illumina Restriction Endonucleases Product Description
6.4.5 Illumina Recent Developments
6.5 Agilent
6.5.1 Agilent Corporation Information
6.5.2 Agilent Overview
6.5.3 Agilent Restriction Endonucleases Sales and Revenue in United States Market (2016-2021)
6.5.4 Agilent Restriction Endonucleases Product Description
6.5.5 Agilent Recent Developments
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Overview
6.6.3 Roche Restriction Endonucleases Sales and Revenue in United States Market (2016-2021)
6.6.4 Roche Restriction Endonucleases Product Description
6.6.5 Roche Recent Developments
6.7 GE Healthcare
6.7.1 GE Healthcare Corporation Information
6.7.2 GE Healthcare Overview
6.7.3 GE Healthcare Restriction Endonucleases Sales and Revenue in United States Market (2016-2021)
6.7.4 GE Healthcare Restriction Endonucleases Product Description
6.7.5 GE Healthcare Recent Developments
6.8 Promega
6.8.1 Promega Corporation Information
6.8.2 Promega Overview
6.8.3 Promega Restriction Endonucleases Sales and Revenue in United States Market (2016-2021)
6.8.4 Promega Restriction Endonucleases Product Description
6.8.5 Promega Recent Developments
6.9 Qiagen
6.9.1 Qiagen Corporation Information
6.9.2 Qiagen Overview
6.9.3 Qiagen Restriction Endonucleases Sales and Revenue in United States Market (2016-2021)
6.9.4 Qiagen Restriction Endonucleases Product Description
6.9.5 Qiagen Recent Developments
6.10 Jena Biosciences
6.10.1 Jena Biosciences Corporation Information
6.10.2 Jena Biosciences Overview
6.10.3 Jena Biosciences Restriction Endonucleases Sales and Revenue in United States Market (2016-2021)
6.10.4 Jena Biosciences Restriction Endonucleases Product Description
6.10.5 Jena Biosciences Recent Developments
7 United States Restriction Endonucleases Production Capacity, Analysis
7.1 United States Restriction Endonucleases Production Capacity, 2016-2027
7.2 Restriction Endonucleases Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Restriction Endonucleases Supply Chain Analysis
9.1 Restriction Endonucleases Industry Value Chain
9.2 Restriction Endonucleases Upstream Market
9.3 Restriction Endonucleases Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Restriction Endonucleases Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Restriction Endonucleases in United States Market
Table 2. Top Restriction Endonucleases Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Restriction Endonucleases Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Restriction Endonucleases Revenue Share by Companies, 2016-2021
Table 5. United States Restriction Endonucleases Sales by Companies, (K Units), 2016-2021
Table 6. United States Restriction Endonucleases Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Restriction Endonucleases Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Restriction Endonucleases Product Type
Table 9. List of Tier 1 Restriction Endonucleases Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Restriction Endonucleases Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Type I
Table 12. Major Manufacturers of Type II
Table 13. By Type - United States Restriction Endonucleases Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Restriction Endonucleases Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Restriction Endonucleases Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Restriction Endonucleases Sales (K Units), 2016-2021
Table 17. By Type - United States Restriction Endonucleases Sales (K Units), 2022-2027
Table 18. By Application - United States Restriction Endonucleases Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Restriction Endonucleases Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Restriction Endonucleases Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Restriction Endonucleases Sales (K Units), 2016-2021
Table 22. By Application - United States Restriction Endonucleases Sales (K Units), 2022-2027
Table 23. New England Biolabs Corporation Information
Table 24. New England Biolabs Description and Major Businesses
Table 25. New England Biolabs Restriction Endonucleases Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. New England Biolabs Restriction Endonucleases Product
Table 27. New England Biolabs Recent Developments
Table 28. Thermo Fisher Scientific Corporation Information
Table 29. Thermo Fisher Scientific Description and Major Businesses
Table 30. Thermo Fisher Scientific Restriction Endonucleases Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Thermo Fisher Scientific Restriction Endonucleases Product
Table 32. Thermo Fisher Scientific Recent Developments
Table 33. Takara Bio Corporation Information
Table 34. Takara Bio Description and Major Businesses
Table 35. Takara Bio Restriction Endonucleases Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Takara Bio Restriction Endonucleases Product
Table 37. Takara Bio Recent Developments
Table 38. Illumina Corporation Information
Table 39. Illumina Description and Major Businesses
Table 40. Illumina Restriction Endonucleases Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Illumina Restriction Endonucleases Product
Table 42. Illumina Recent Developments
Table 43. Agilent Corporation Information
Table 44. Agilent Description and Major Businesses
Table 45. Agilent Restriction Endonucleases Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Agilent Restriction Endonucleases Product
Table 47. Agilent Recent Developments
Table 48. Roche Corporation Information
Table 49. Roche Description and Major Businesses
Table 50. Roche Restriction Endonucleases Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Roche Restriction Endonucleases Product
Table 52. Roche Recent Developments
Table 53. GE Healthcare Corporation Information
Table 54. GE Healthcare Description and Major Businesses
Table 55. GE Healthcare Restriction Endonucleases Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. GE Healthcare Restriction Endonucleases Product
Table 57. GE Healthcare Recent Developments
Table 58. Promega Corporation Information
Table 59. Promega Description and Major Businesses
Table 60. Promega Restriction Endonucleases Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Promega Restriction Endonucleases Product
Table 62. Promega Recent Developments
Table 63. Qiagen Corporation Information
Table 64. Qiagen Description and Major Businesses
Table 65. Qiagen Restriction Endonucleases Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Qiagen Restriction Endonucleases Product
Table 67. Qiagen Recent Developments
Table 68. Jena Biosciences Corporation Information
Table 69. Jena Biosciences Description and Major Businesses
Table 70. Jena Biosciences Restriction Endonucleases Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Jena Biosciences Restriction Endonucleases Product
Table 72. Jena Biosciences Recent Developments
Table 73. Restriction Endonucleases Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 74. United States Restriction Endonucleases Capacity Market Share of Key Manufacturers, 2019-2021
Table 75. Restriction Endonucleases Market Opportunities & Trends in United States Market
Table 76. Restriction Endonucleases Market Drivers in United States Market
Table 77. Restriction Endonucleases Market Restraints in United States Market
Table 78. Restriction Endonucleases Raw Materials
Table 79. Restriction Endonucleases Raw Materials Suppliers in United States Market
Table 80. Typical Restriction Endonucleases Downstream
Table 81. Restriction Endonucleases Downstream Clients in United States Market
Table 82. Restriction Endonucleases Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Restriction Endonucleases Product Picture
Figure 2. Restriction Endonucleases Segment by Type
Figure 3. Restriction Endonucleases Segment by Application
Figure 4. United States Restriction Endonucleases Market Overview: 2020
Figure 5. United States Restriction Endonucleases Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Restriction Endonucleases Revenue, 2016-2027 (US$, Mn)
Figure 7. Restriction Endonucleases Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Restriction Endonucleases Revenue in 2020
Figure 9. Type I Product Picture
Figure 10. Type II Product Picture
Figure 11. Type III Product Picture
Figure 12. Type IV Product Picture
Figure 13. Others Product Picture
Figure 14. By Type - United States Restriction Endonucleases Sales Market Share, 2016-2027
Figure 15. By Type - United States Restriction Endonucleases Revenue Market Share, 2016-2027
Figure 16. By Type - United States Restriction Endonucleases Price (USD/Unit), 2016-2027
Figure 17. Academic & Research Institutes
Figure 18. Hospitals & Diagnostic Centers
Figure 19. Biopharmaceutical
Figure 20. Others
Figure 21. By Application - United States Restriction Endonucleases Sales Market Share, 2016-2027
Figure 22. By Application - United States Restriction Endonucleases Revenue Market Share, 2016-2027
Figure 23. By Application - United States Restriction Endonucleases Price (USD/Unit), 2016-2027
Figure 24. New England Biolabs Restriction Endonucleases Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Thermo Fisher Scientific Restriction Endonucleases Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Takara Bio Restriction Endonucleases Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Illumina Restriction Endonucleases Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Agilent Restriction Endonucleases Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Roche Restriction Endonucleases Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. GE Healthcare Restriction Endonucleases Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Promega Restriction Endonucleases Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Qiagen Restriction Endonucleases Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Jena Biosciences Restriction Endonucleases Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. United States Restriction Endonucleases Production Capacity (K Units), 2016-2027
Figure 35. Restriction Endonucleases Industry Value Chain
Figure 36. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Erythrocyte Catalase Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Erythrocyte Catalase market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Erythrocyte Catalase is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Erythrocyte Catalase is estimated to increase from $ million in 2023 to reach $ millio......

Global Endoenzyme Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88

The global Endoenzyme market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The application scenarios of endozymes are very wide and can be used in many fields such as chemical reagents, medical treatment, and environmental protection. With The continuous development of science and technology, The application scenarios of endozymes will continue to expand. This will further promote......

Global CASP9 Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

CASP9 (Caspase 9) is a Protein Coding gene. Diseases associated with CASP9 include Cerebral Hypoxia and Colorectal Cancer. Among its related pathways are TNFR1 Pathway and Apoptosis and survival FAS signaling cascades. Gene Ontology (GO) annotations related to this gene include protein kinase binding and peptidase activity. An important paralog of this gene is CASP2. The global CASP9 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing......

Global Collagenase Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 78

Collagenase, obtained from Clostridium histolyticum, is an enzyme used for tissue dissociation in vitro and thus for isolation of many different types of cells. These isolated cells are then used for numerous clinical and research applications. The global Collagenase market was valued at US$ 79 million in 2023 and is anticipated to reach US$ 92 million by 2030, witnessing a CAGR of 2.2% during The forecast period 2024-2030. The global collagenase market is mainly compos......

Global Industrial Enzymes Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 123

Enzymes are protein molecules functioning as specialized catalysts for chemical reactions. They have contributed greatly to The traditional and modern chemical industry by improving existing processes. Enzymes are natural catalysts. They are produced by living organisms to increase The rate of an immense and diverse set of chemical reactions required for life. They are involved in all processes essential for life such as DNA replication and transcription, protein synthesis, metabolism and signal......

Global Phytases Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Phytases market size was valued at US$ 490.1 million in 2023. With growing demand in downstream market, the Phytases is forecast to a readjusted size of US$ 732.7 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Phytases market. Phytases are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Trypsin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Trypsin market size was valued at US$ 214.3 million in 2023. With growing demand in downstream market, the Trypsin is forecast to a readjusted size of US$ 374.5 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Trypsin market. Trypsin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......

Global Cellulase Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Cellulase market size was valued at US$ 1980 million in 2023. With growing demand in downstream market, the Cellulase is forecast to a readjusted size of US$ 3084 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Cellulase market. Cellulase are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......

Global Restriction Endonucleases Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107

According to our LPI (LP Information) latest study, the global Restriction Endonucleases market size was valued at US$ 263.7 million in 2023. With growing demand in downstream market, the Restriction Endonucleases is forecast to a readjusted size of US$ 397 million by 2030 with a CAGR of 6.0% during review period. The research report highlights the growth potential of the global Restriction Endonucleases market. Restriction Endonucleases are expected to show stable growth in the future m......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs